Syndax Pharmaceuticals (SNDX) FCF Margin Growth (1y) (2016 - 2026)
Syndax Pharmaceuticals (SNDX) FCF Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Syndax Pharmaceuticals |
1.69 Bn |
1.34 Bn |
53.02 Mn |
39,720.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
39,720.00 |
| Dec 31, 2025 |
64,605.00 |
| Sep 30, 2025 |
34,481.00 |
| Jun 30, 2025 |
181,570.00 |
| Dec 31, 2021 |
419,299.00 |
| Sep 30, 2021 |
462,614.00 |
| Jun 30, 2021 |
-69,604.00 |
| Mar 31, 2021 |
-175,831.00 |
| Dec 31, 2020 |
-76,421.00 |
| Sep 30, 2020 |
-257,731.00 |
| Jun 30, 2020 |
-234,354.00 |
| Mar 31, 2020 |
23,905.00 |
| Dec 31, 2019 |
61,316.00 |
| Sep 30, 2019 |
262,269.00 |
| Jun 30, 2019 |
69,235.00 |
| Mar 31, 2019 |
84,749.00 |
| Dec 31, 2018 |
-289,246.00 |
| Sep 30, 2018 |
-153,473.00 |
| Jun 30, 2018 |
-12,825.00 |
| Mar 31, 2018 |
-113,495.00 |
